Rheumatology NewsSystemic psoriasis treatment may resolve subclinical enthesitisMay 1, 2015Psoriatic ArthritisSpondyloarthropathies
Rheumatology NewsNew tool aims to improve monitoring of psoriatic arthritisMay 1, 2015Psoriatic ArthritisSpondyloarthropathies
Rheumatology NewsOlder psoriasis patients experience more adverse eventsApril 29, 2015SpondyloarthropathiesPsoriatic Arthritis
Rheumatology NewsLate-onset psoriasis genetics identifiedApril 28, 2015SpondyloarthropathiesPsoriatic Arthritis
Rheumatology NewsNew psoriatic arthritis screening tool passes initial validationApril 17, 2015Psoriatic ArthritisSpondyloarthropathies
Rheumatology NewsPsoriatic arthritis associated with heavy drinkingApril 17, 2015Psoriatic ArthritisSpondyloarthropathies
Rheumatology NewsApremilast meets psoriasis endpoints at week 32April 12, 2015SpondyloarthropathiesPsoriatic Arthritis
Rheumatology NewsIxekizumab met psoriasis endpoints by week 12, with durable response at 60 weeksApril 9, 2015Psoriatic ArthritisSpondyloarthropathies
Rheumatology NewsIL-23 inhibitor topped ustekinumab against psoriasisApril 2, 2015Psoriatic ArthritisSpondyloarthropathies
Rheumatology NewsTraditional risk factors raise cardiovascular risk in PsAApril 2, 2015SpondyloarthropathiesPsoriatic Arthritis
Rheumatology NewsNo increased risk of lung disease with methotrexateApril 2, 2015Psoriatic ArthritisSpondyloarthropathies
Rheumatology NewsRheumatologists support biosimilars, with caveatsApril 1, 2015Ankylosing spondylitisPsoriatic ArthritisSpondyloarthropathiesRheumatoid ArthritisBusiness of Medicine
Rheumatology NewsMethotrexate and biologics linked to higher zoster risk in psoriasisMarch 22, 2015Psoriatic ArthritisSpondyloarthropathies
Rheumatology NewsSecukinumab beat ustekinumab for psoriasis, with difference by week fourMarch 21, 2015SpondyloarthropathiesPsoriatic Arthritis
Rheumatology NewsBrodalumab achieved primary endpoints for moderate to severe psoriasis at 52 weeksMarch 21, 2015SpondyloarthropathiesPsoriatic Arthritis
